The Association of the British Pharmaceutical Industry (ABPI) has welcomed NHS England’s new publication summarising the recent regional workshops held on biosimilar medicines.
This report has been developed by an independent expert working group and supported by the ABPI Dermatology Initiative.
Dr Sheuli Porkess, ABPI's Head of Medical Affairs, says:
Collaboration between the pharmaceutical industry, patients and health regulators will be a ‘game changer’ in delivering exciting new cell and gene therapies to treat conditions like cancer and vision loss says a new review article published in Frontiers in Medicine, written by Association of the...
The report published today by the Academy of Medical Sciences describes an urgent and serious challenge about how we ensure that patients, their carers and the healthcare professionals that support them, feel able to trust their medicines and the research evidence that underpins them.
The Government has today [13 July] published new data on the use of animals in the research and development of medicines in the UK. These annual statistics relating to scientific procedures performed on living animals are published in accordance with the Animals (Scientific Procedures) Act 1986.
The pharmaceutical industry typically employs doctors in very distinctive roles which can be related broadly to the medical responsibilities. Each role requires appropriate qualifications. Larger companies often employ specialists while, in smaller companies, some or all of the roles may be combined...
Medicines development is the process of formulating, testing and evaluating a potential new medicine as it moves from the laboratory to the clinic. Chemists, biologists and pharmacologists with a research science background usually undertake early research.
The majority of companies require physicians to be licensed with the General Medical Council (GMC) for entry into the industry, particularly in medical affairs roles.
Should pharmaceutical physicians wish to change career course in the industry, there are various opportunities to explore. This is where experience of different areas (e.g. pharmacovigilance and medical affairs) can be beneficial.
The Life Sciences Industrial Strategy was launched, and received, with much enthusiasm this week at the Institute of Translational Medicine. It was a fitting venue: a world-class clinical research facility in Birmingham that helps progress scientific research into the latest treatments for NHS...